SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,891,954 | +5.0% | 122,851 | -0.8% | 0.02% | +6.2% |
| Q2 2023 | $14,184,676 | +95898.1% | 123,862 | +15.5% | 0.02% | -11.1% |
| Q1 2023 | $14,776 | +13.1% | 107,205 | +6.3% | 0.02% | 0.0% |
| Q4 2022 | $13,065 | -99.9% | 100,828 | +7.4% | 0.02% | +20.0% |
| Q3 2022 | $10,375,000 | +56.9% | 93,853 | +6.4% | 0.02% | +50.0% |
| Q2 2022 | $6,613,000 | +8.1% | 88,219 | +12.7% | 0.01% | +25.0% |
| Q1 2022 | $6,115,000 | -16.7% | 78,272 | -3.9% | 0.01% | -11.1% |
| Q4 2021 | $7,338,000 | +7.6% | 81,484 | +10.5% | 0.01% | 0.0% |
| Q3 2021 | $6,822,000 | +18.2% | 73,767 | -0.6% | 0.01% | +12.5% |
| Q2 2021 | $5,771,000 | -1.2% | 74,241 | -5.2% | 0.01% | 0.0% |
| Q1 2021 | $5,839,000 | -59.3% | 78,342 | -6.8% | 0.01% | -60.0% |
| Q4 2020 | $14,334,000 | +18.8% | 84,078 | -2.1% | 0.02% | +5.3% |
| Q3 2020 | $12,064,000 | -15.4% | 85,906 | -3.4% | 0.02% | -20.8% |
| Q2 2020 | $14,258,000 | +96.1% | 88,925 | +19.6% | 0.02% | +60.0% |
| Q1 2020 | $7,271,000 | -24.5% | 74,326 | -0.5% | 0.02% | -6.2% |
| Q4 2019 | $9,636,000 | +77.7% | 74,678 | +3.7% | 0.02% | +60.0% |
| Q3 2019 | $5,423,000 | -50.9% | 72,003 | -0.9% | 0.01% | -52.4% |
| Q2 2019 | $11,039,000 | +37.9% | 72,647 | +8.2% | 0.02% | +31.2% |
| Q1 2019 | $8,005,000 | +7.8% | 67,165 | -1.3% | 0.02% | 0.0% |
| Q4 2018 | $7,425,000 | -32.7% | 68,037 | -0.3% | 0.02% | -23.8% |
| Q3 2018 | $11,026,000 | +23.9% | 68,267 | +1.4% | 0.02% | +16.7% |
| Q2 2018 | $8,900,000 | +97.4% | 67,332 | +10.6% | 0.02% | +100.0% |
| Q1 2018 | $4,509,000 | +31.7% | 60,859 | -1.1% | 0.01% | +28.6% |
| Q4 2017 | $3,424,000 | +4.0% | 61,542 | -15.2% | 0.01% | 0.0% |
| Q3 2017 | $3,291,000 | +58.8% | 72,543 | +18.0% | 0.01% | +40.0% |
| Q2 2017 | $2,072,000 | +16.5% | 61,462 | +2.3% | 0.01% | +25.0% |
| Q1 2017 | $1,778,000 | +11.8% | 60,079 | +3.6% | 0.00% | 0.0% |
| Q4 2016 | $1,591,000 | -45.7% | 57,997 | +21.7% | 0.00% | -50.0% |
| Q3 2016 | $2,928,000 | +228.6% | 47,674 | +2.0% | 0.01% | +166.7% |
| Q2 2016 | $891,000 | -0.8% | 46,719 | +1.6% | 0.00% | 0.0% |
| Q1 2016 | $898,000 | -51.2% | 45,998 | -3.6% | 0.00% | -50.0% |
| Q4 2015 | $1,841,000 | +39.5% | 47,728 | +16.1% | 0.01% | +50.0% |
| Q3 2015 | $1,320,000 | +9.8% | 41,113 | +4.1% | 0.00% | 0.0% |
| Q2 2015 | $1,202,000 | +118.9% | 39,512 | -4.5% | 0.00% | +100.0% |
| Q1 2015 | $549,000 | +12.0% | 41,357 | +22.1% | 0.00% | +100.0% |
| Q4 2014 | $490,000 | -33.7% | 33,882 | -3.3% | 0.00% | -50.0% |
| Q3 2014 | $739,000 | -35.9% | 35,032 | -9.5% | 0.00% | -33.3% |
| Q2 2014 | $1,153,000 | +35.3% | 38,697 | +9.1% | 0.00% | 0.0% |
| Q1 2014 | $852,000 | +25.8% | 35,463 | +6.7% | 0.00% | +50.0% |
| Q4 2013 | $677,000 | -55.0% | 33,223 | +4.4% | 0.00% | -60.0% |
| Q3 2013 | $1,503,000 | +40.3% | 31,813 | +13.0% | 0.01% | +66.7% |
| Q2 2013 | $1,071,000 | – | 28,160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |